Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Perkins

Showing results (171-180 of 173) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 173 results.
Neurogastroenterology and Motility|October 30, 2013
Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjectsG Chaddock, C Lam, C L Hoad, et al.
Cancer Research|November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein doseA C van Hof, C F Molthoff, Q Davies, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 1998
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01H M Prinssen, C F Molthoff, R H Verheijen, et al.
Pageof 18

Showing results (171-180 of 173) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 173 results.
Neurogastroenterology and Motility|October 30, 2013
Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjectsG Chaddock, C Lam, C L Hoad, et al.
Cancer Research|November 15, 1996
Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein doseA C van Hof, C F Molthoff, Q Davies, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 1998
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01H M Prinssen, C F Molthoff, R H Verheijen, et al.
Pageof 18